Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-141 Cr₹-146 Cr₹-134 Cr₹-113 Cr₹-103 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-141 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-141 Cr
Mar2024₹-146 Cr
Mar2023₹-134 Cr
Mar2022₹-113 Cr
Mar2021₹-103 Cr

How is Deferred Tax Assets / Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-141 Cr
Negative
Mar2024 ₹-146 Cr
Negative
Mar2023 ₹-134 Cr
Negative
Mar2022 ₹-113 Cr
Negative
Mar2021 ₹-103 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹39,463.4 Cr -2.9% -9.8% 13.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,541.0 Cr -3.6% -6.8% -5.6% Stock Analytics
DIVIS LABORATORIES ₹163,031.0 Cr -5.4% -2.4% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,451.0 Cr 3.6% 8.5% 23.5% Stock Analytics
CIPLA ₹112,377.0 Cr -5.1% -7.1% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹97,355.5 Cr -4.1% -8.3% -12.1% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-2.9%

-9.8%

13.1%

SENSEX

-0.4%

-1.7%

9.1%


You may also like the below Video Courses